top of page
Our Leadership Team
Led by a combination of science, medical and business experience
Dr Nigel Saunders
Chief Scientific Officer
Nigel is an expert in medical bacteriology, functional and comparative genomics, bacterial systems and evolutionary biology.
He was the first recipient of the Wellcome Trust Fellowship in Medical Microbiology.
For 11 years, Nigel was the Principle Investigator of the Bacterial Pathogenesis and Functional Genomics Group at The Sir William Dunn School of Pathology, University of Oxford. For nine years, he was the First Interdisciplinary Chair of Systems and Synthetic Biology (Computer Science, Maths, & Biological Sciences) at Brunel University London.
Nigel is also one of the founding managers of the Oxford University Computational Biology Research Group.
Nigel is an expert in medical bacteriology, functional and comparative genomics, bacterial systems and evolutionary biology.
He was the first recipient of the Wellcome Trust Fellowship in Medical Microbiology.
For 11 years, Nigel was the Principle Investigator of the Bacterial Pathogenesis and Functional Genomics Group at The Sir William Dunn School of Pathology, University of Oxford. For nine years, he was the First Interdisciplinary Chair of Systems and Synthetic Biology (Computer Science, Maths, & Biological Sciences) at Brunel University London.
Nigel is also one of the founding managers of the Oxford University Computational Biology Research Group.
Dr John Peden
Chief Bioinformatician
John is one of the World's leading bioinformaticians....
Until recently, John was Senior Staff Bioinformatician at Illumina, a global leader in genomics, having spent over ten years with the firm.
Previously, he was a Senior Bioinformatician at the Wellcome Trust Centre for Human Genetics, and before that, he was a Manager at Oxford University's Bioinformatics Centre.
John is one of the World's leading bioinformaticians....
Until recently, John was Senior Staff Bioinformatician at Illumina, a global leader in genomics, having spent over ten years with the firm.
Previously, he was a Senior Bioinformatician at the Wellcome Trust Centre for Human Genetics, and before that, he was a Manager at Oxford University's Bioinformatics Centre.
Julian Hardy
Chief Executive Officer
Julian is a serial entrepreneur with a proven track record of rapidly forming and building companies to the point of product and revenue delivery. He has been at the forefront of several innovative high-growth technology sectors – including IoT, mobile gaming, crypto and Biotech – bringing highly differentiated solutions to market and executing on a big vision.
Julian is a serial entrepreneur with a proven track record of rapidly forming and building companies to the point of product and revenue delivery. He has been at the forefront of several innovative high-growth technology sectors – including IoT, mobile gaming, crypto and Biotech – bringing highly differentiated solutions to market and executing on a big vision.
Ray Schaaf
Chief Operating Officer
Ray has over 30 years of experience spanning hardware computing, wireless, digital content, and e-commerce industries. He has held numerous executive positions managing companies in the USA, Asia, and Europe. He focuses on building successful companies with high-quality teams that deliver innovative products and services to the market.
Ray has over 30 years of experience spanning hardware computing, wireless, digital content, and e-commerce industries. He has held numerous executive positions managing companies in the USA, Asia, and Europe. He focuses on building successful companies with high-quality teams that deliver innovative products and services to the market.
Kieran Fontaine
Chief Strategy Officer
Kieran has held various senior positions and was part of the investment team for one of the world’s leading hedge funds. He has over a decade of experience managing people and creating value by identifying new disruptive trends across challenging global markets.
Kieran has held various senior positions and was part of the investment team for one of the world’s leading hedge funds. He has over a decade of experience managing people and creating value by identifying new disruptive trends across challenging global markets.
Dr Susie Jerwood
Chief Medical Officer
Susie has a background as a medical microbiologist, having trained across the South Coast of England and was previously a consultant in infection at University Hospitals Sussex. Her early consultant career focused on antimicrobial stewardship before specialising in infection prevention and becoming the Trust’s Infection Control Doctor for six years.
She also gained experience in management whilst spending five years as the Clinical Director for Pathology.
Currently, Susie is using her experience in hospital medicine and infection prevention and control to demonstrate the benefits of whole genome sequencing in exposing and preventing healthcare-associated infections
Susie has a background as a medical microbiologist, having trained across the South Coast of England and was previously a consultant in infection at University Hospitals Sussex. Her early consultant career focused on antimicrobial stewardship before specialising in infection prevention and becoming the Trust’s Infection Control Doctor for six years.
She also gained experience in management whilst spending five years as the Clinical Director for Pathology.
Currently, Susie is using her experience in hospital medicine and infection prevention and control to demonstrate the benefits of whole genome sequencing in exposing and preventing healthcare-associated infections
Jonathan Anscombe
Head of Strategic Alliances
Jonathan is a senior healthcare executive. As a senior partner at A.T. Kearney Management Consultants, he led the European Healthcare Practice. He also founded NEXT Consulting providing Software as a Service technology solution.
Over a 30-year career, Jonathan has worked with leading pharma and medical technology companies, health insurers, care providers and governments, helping to develop and launch digital healthcare solutions, launch and improve access to new therapies, pricing and health system design.
Jonathan is a senior healthcare executive. As a senior partner at A.T. Kearney Management Consultants, he led the European Healthcare Practice. He also founded NEXT Consulting providing Software as a Service technology solution.
Over a 30-year career, Jonathan has worked with leading pharma and medical technology companies, health insurers, care providers and governments, helping to develop and launch digital healthcare solutions, launch and improve access to new therapies, pricing and health system design.
Lorena Szerman
Head of Sales and Business Development
Our amazing team
Our team are all driven with the same passion to make a difference
Our advisory board
Our senior advisors bring a wealth of experience to Genpax
Professor Jonathan Cohen
Prof. Emeritus & Senior Advisor
Professor Cohen is an Emeritus Professor of Infectious Diseases at Brighton and Sussex Medical School, where he specialized in treating severe bacterial infections. He was the first Chair of Infectious Disease at the Royal Postgraduate Medical School / Hammersmith Hospital, President of the International Society for Infectious Diseases, and a NED at Kings College Hospital NHS Trust since 2015.
He worked for 11 years as the founding Dean of Brighton and Sussex Medical School. Jon has published >200 papers on research and clinical trials into septic shock and spent five years as Editor-in-Chief of the International Journal of Infectious Diseases.
Professor Cohen is an Emeritus Professor of Infectious Diseases at Brighton and Sussex Medical School, where he specialized in treating severe bacterial infections. He was the first Chair of Infectious Disease at the Royal Postgraduate Medical School / Hammersmith Hospital, President of the International Society for Infectious Diseases, and a NED at Kings College Hospital NHS Trust since 2015.
He worked for 11 years as the founding Dean of Brighton and Sussex Medical School. Jon has published >200 papers on research and clinical trials into septic shock and spent five years as Editor-in-Chief of the International Journal of Infectious Diseases.
Professor David Livermore
Prof. Emeritus & Senior Advisor
For 40 years, Professor Livermore has belonged to – then led – teams that have defined the evolving epidemiology and molecular nature of antimicrobial resistance; and was Head of the UK National Reference Laboratory for antimicrobial resistance.
He has authored over 500 papers, has edited for multiple journals and has served on UK government advisory committees on antimicrobial resistance and healthcare infection. David now works part-time for the University of East Anglia while also consulting the medical industry on antibiotic development and rapid diagnostics.
For 40 years, Professor Livermore has belonged to – then led – teams that have defined the evolving epidemiology and molecular nature of antimicrobial resistance; and was Head of the UK National Reference Laboratory for antimicrobial resistance.
He has authored over 500 papers, has edited for multiple journals and has served on UK government advisory committees on antimicrobial resistance and healthcare infection. David now works part-time for the University of East Anglia while also consulting the medical industry on antibiotic development and rapid diagnostics.
bottom of page